SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-200653
Filing Date
2021-06-28
Accepted
2021-06-25 17:32:41
Documents
7
Effectiveness Date
2021-06-28

Document Format Files

Seq Description Document Type Size
1 S-8 d154366ds8.htm S-8 70514
2 EX-5.1 d154366dex51.htm EX-5.1 9964
3 EX-23.1 d154366dex231.htm EX-23.1 4056
4 GRAPHIC g154366dsp12.jpg GRAPHIC 3341
5 GRAPHIC g154366dsp13.jpg GRAPHIC 2125
6 GRAPHIC g154366g34t38.jpg GRAPHIC 4240
7 GRAPHIC g154366g77b22.jpg GRAPHIC 2713
  Complete submission text file 0001193125-21-200653.txt   103587
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257446 | Film No.: 211049156
SIC: 2836 Biological Products, (No Diagnostic Substances)